Spelling suggestions: "subject:"sterile difiltration"" "subject:"sterile anofiltration""
1 |
The use of fluorescently labeled nanoparticles as therapeutic virus surrogates in sterile filtration studiesPazouki, Mohammadreza January 2018 (has links)
Nanoparticles (NPs) have attracted considerable attention in the field of separation science, especially in filtration studies for direct membrane integrity tests, investigating pore-size distribution, and their potential to be used as surrogates for various types of viruses encountered in water treatment and bioprocessing applications. Although the effect of adding surfactants to stabilize NP suspension have been explored for a number of different applications, there is significant variation in the amounts and types of surfactants used in filtration studies. This study used three different sizes (59, 188, and 490 nm) of fluorescent polystyrene nanoparticles (PNPs) to mimic the length, width, and aggregates of Rhabdovirus Maraba, a bullet-shape envelope virus. The PNPs were suspended in solutions with varying concentrations of the nonionic surfactant Tween 20 (0.0005% to 0.1% (v/v) in the carbonate buffer feed solution) and were tested in constant-flux filtration studies using two commercial microfiltration (MF) membranes (Durapore PVDF and MiniSart PES) with 0.22 micron pore size ratings. Results clearly demonstrate that adding a nonionic surfactant to a PNP solution will cause a shift from full retention to complete transmission during the dead-end MF of PNPs that are smaller than the pore size of an MF membrane. In a separate study, in order to have a better resemblance of virus particles in terms of surface properties, 188 nm PNPs were coated with different (lysozyme, α -lactalbumin and bovine serum albumin) proteins in order to gain similar surface properties to actual virus particles. Filtration results with one type of commercial MF membranes (Durapore PVDF) 0.22 μm pore size, clearly indicate that the transmission behavior of PNPs strongly depends on their surface properties. PNPs fully covered with BSA and α–lactalbumin could completely pass through the membranes while uncovered or partially covered PNPs resulted in no transmission or partial transmission. / Thesis / Master of Applied Science (MASc) / Nanoparticles (NPs) has been employed enormously in various applications for a variety of purposes. One of the areas that have been greatly influenced by NPs, is the field of separation science. In the pharmaceutical industry, purification of therapeutics involves a sequence of filtration and in this step, therapeutic virus filtration, sterile filtration, in particular, have been poorly studied. There is also a growing interest in the use of engineered viruses for cancer treatment due to its magnificent implication on human health. However, there are significant challenges in running filtration experiments with pathogenic substances. Therefore it has been determined that a detailed and comprehensive study of sterile filtration of virus-size NPs can benefit this area. In this work, fluorescently-labeled NPs has been used as surrogates of oncolytic viruses to extract fundamental aspects affecting the transmission of virus-sized particles through commercial microfiltration sterilizing grade membranes.
|
2 |
A multifaceted approach towards advancing the sterile filtration of therapeutic virusesWright, Evan January 2022 (has links)
Therapeutic viruses are a class of biotherapeutic which have enabled new treatments and medical advances in the areas of vaccines, cancer treatment, gene therapy, and more. In the production and purification of these products, the sterile filtration unit operation is known to have poor yields and contribute to the high cost of the final product, significantly hampering the large-scale production of some therapeutic viruses. Thus, this thesis seeks to explore various aspects of process development and fundamental understanding in the sterile filtration of therapeutic viruses. This thesis explores the mechanisms and membrane properties which govern how bacteria are retained during filtration, and applies these insights to improve the sterile filtration recovery of a therapeutic virus through proper membrane selection. To better understand the factors which cause membrane fouling and loss of virus during sterile filtration, the effect of host cell impurities on filtration performance was investigated. This revealed that small amounts of host cell protein are a major factor in both membrane fouling and reduced virus yield, and that there is a synergistic effect between the virus and the host cell protein adsorbing to the membrane surface. Recognizing that conventional polymeric membranes have many limitations, a novel ultrathin, isoporous, microfabricated silicon nitride membrane was tested for suitability as a sterile filter. Finally, the application of nanoparticles as model virus particles in filtration testing was examined, and a process was developed through which nanoparticles could be fused together to create controlled amounts of particle aggregates, similar to how viruses can be prone to aggregation. The work described here will help enable the development of next generation sterile filtration membranes and provides both insights and methodologies for improving sterile filtration performance. / Thesis / Doctor of Philosophy (PhD) / While many people are aware that viruses can be used in medicine as vaccines, there are even more new and developing ways they can be used, such as in fighting cancer or treating previously uncurable diseases. However, testing of and patient access to these new treatments is often limited due to the challenges in producing and purifying enough of the virus. Viruses are highly complex and large relative to other products, and so many of the common methods and manufacturing processes which are standard in the industry need to be significantly adapted or improved to suit the production of viruses. This study investigates one step of the purification process, sterile filtration, and considers how a variety of factors from the materials used to the properties of the virus solution can be optimized to improve performance. With a deeper understanding of the sterile filtration process, recommendations can be made to help improve the production of future virus-based therapies.
|
3 |
Addressing the Downstream Processing Challenges Within Manufacturing of Oncolytic RhabdovirusesShoaebargh, Shabnam January 2019 (has links)
Oncolytic viruses (OVs) are a class of cancer therapy that is currently undergoing clinical trials on its way to full regulatory approval. At present, the downstream processing of OVs relies on a combination of chromatography and membrane-based processes to remove process-related (e.g. host-cell proteins and nucleic acids) and product-related impurities (e.g. aggregated virus particles). This thesis explores various methods that can potentially be used to address the challenges associated with downstream processing during the production of OVs. To this end, the Rhabdoviral vector, which is currently undergoing clinical trials (phase I/II) for use in treating advanced or metastatic solid tumors, was selected as a promising oncolytic virus.
One potential improvement in the downstream process that was investigated was the use of monolithic column chromatography for Rhabdovirus purification. Two monolithic anion-exchange columns (2 and 6 µm pore size) and one hydrophobic interaction column (6 µm pore size) were used to examine how column pore size affects virus recovery and contaminant removal. This investigation ultimately inspired the development of a purification process based on monolithic hydrophobic interaction column chromatography. Furthermore, this work is also the first to investigate how additives, namely glycerol, impact the hydrophobic interaction chromatography of virus particles. The developed process could be readily implemented for the scaled-up purification of the Rhabdoviral vector.
Another challenge associated with the downstream processing of OVs is membrane fouling, which is characterized by a dramatic rise in transmembrane pressure (TMP) and low virus recovery. Indeed, membrane fouling poses a significant challenge, as some recent studies have reported that it can result in viral vector titer losses of over 80%. One critical use of membranes in downstream processing is for the sterile filtration of OVs, which is a required final step that is conducted right before vialing and involves passing the virus particles through a validated sterile filter. One of the main objectives of this thesis was to develop a fundamental understanding of the sterile filtration process and to optimize it in order to achieve higher throughput and lower losses, which are both essential to the large-scale production of OVs. To this end, a dead-end sterile filtration setup was designed, and various commercially available filters were evaluated to examine how membrane morphology affects fouling and product recovery. The results of these tests showed that double-layered composite filters enabled higher virus recovery and filtration capacity compared to single-layered sterile filters.
Another cause of membrane fouling is the aggregation of virus particles, which is mediated by various interactions in the solution. To study this, the above-described setup was re-designed to create an effective procedure that utilizes minimal volumes of virus solution, while also enabling the rapid assessment of microscale filtration performance and a comprehensive understanding of virus-virus and virus-membrane interactions. This setup was used to study how different additives, including various proteins (bovine serum albumin and α-lactalbumin) and polymers (polyethylene glycol and polyvinylpyrrolidone), affect the microfiltration of the Rhabdoviral vector and, consequently, the TMP profile. Furthermore, the correlation between the membrane fouling rate (via TMP profiles) and virus recovery was also investigated. This investigation revealed that proteins significantly increase virus transmission and that polymers are incapable of mimicking the effects of the proteins.
To explain this phenomenon, a theory based on the biophysical structure of proteins, mainly heterogenicity in charge distribution, was proposed. Moreover, membrane surface modification tests were conducted using bovine serum albumin, with the results indicating that this approach has considerable potential for enhancing virus transmission. Due to the similarities between the test setup and actual downstream processing unit operations, the results from this part of the thesis could be easily and accurately applied to process optimization. / Thesis / Candidate in Philosophy / There is considerable interest in the development of oncolytic viruses for cancer immunotherapy. Indeed, at the time of this thesis’ writing, a Canadian team of researchers is conducting the world’s first clinical trial using a combination of two viruses to kill cancer cells and stimulate an immune response. The process of manufacturing oncolytic viruses is generally divided into two major steps: upstream processing and downstream processing. While upstream processing focuses on virus propagation, downstream processing aims at removing process-related and product-related impurities. However, research into downstream process design and optimization has largely been neglected in favour of a focus on upstream processing, aimed at increasing bioreactor yields and achieving high viral titers. Consequently, downstream processing has become the main bottleneck in virus manufacturing processes, accounting for as much as 70% production costs. This thesis aims to identify and develop a fundamental understanding of the main challenges associated with the downstream processing of oncolytic viruses and to investigate methods for addressing them. Specifically, the present work focuses on the purification and final sterile filtration steps in the manufacturing of oncolytic Rhabdoviral vectors.
|
Page generated in 0.5391 seconds